Concepedia

Megan Stringer

MS

Statistics

Publications

7

Citations

229

H-Index

7

Active since

1985

Affiliations

Indiana University – Purdue University Indianapolis(Current)

St Bartholomew's Hospital

Megan Stringer is an author at Indiana University – Purdue University Indianapolis specializing in life sciences, down syndrome, and neuroscience.

Publications per year

1985–2023

7

Publications

7

Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes

Megan Stringer, Irushi Abeysekera, Jared Thomas et al. · Physiology & Behavior · 2017 · 59 citations · Full text

Life Sciences, Genetics, Neuroscience +8

NITROUS OXIDE INHALATION DOES NOT INFLUENCE PLASMA CONCENTRATIONS OF (3-ENDORPHIN OR MET-ENKEPHALIN-LIKE IMMUNOREACTIVITY

Stephen F Evans, Megan Stringer, M.D.G. BUKHT et al. · British Journal of Anaesthesia · 1985 · 48 citations · Full text

Life Sciences, Pharmacology, Physiology +4

Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice

Charles R. Goodlett, Megan Stringer, Jonathan LaCombe et al. · Scientific Reports · 2020 · 44 citations · Full text

Life Sciences, Genetics, Pharmacology +14

Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model

Megan Stringer, Irushi Abeysekera, Karl J. Dria et al. · Pharmacology Biochemistry and Behavior · 2015 · 42 citations

Medicine, Neurology, Neuroscience +7

DECAY OF NITROPRUSSIDE. I: IN VITRO

C.J. VESEY, Megan Stringer, P. V. Cole · British Journal of Anaesthesia · 1990 · 15 citations · Full text

Medicine, Pharmacology, Bioavailability +4

1–5 of 7